Close Menu

This article has been updated to include comments from PacBio management made during a conference call.

NEW YORK (GenomeWeb) – Pacific Biosciences reported after the close of the market Tuesday that its first quarter 2015 revenues climbed 52 percent.

The Menlo Park, California-based single-molecule sequencing technologies firm reported Q1 revenues of $17.6 million compared to $11.6 million in Q1 2014. It beat the consensus Wall Street estimate of $13.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.